People who receive Pfizer’s respiratory syncytial virus vaccine should be monitored for Guillain-Barré syndrome, according to the authors of a Pfizer-funded study published this week…
May 20, 2024
People who receive Pfizer’s respiratory syncytial virus vaccine should be monitored for Guillain-Barré syndrome, according to the authors of a Pfizer-funded study published this week…